NeoTYPE® Cholangiocarcinoma Profile
Also known as: Cholangiocarcinoma Profile
Use
The NeoTYPE Cholangiocarcinoma Profile analyzes 19 biomarkers through a combination of next-generation sequencing (NGS), FISH, and IHC. Test orders include summary interpretation of all results to help guide treatment decisions. An indeterminate microsatellite instability (MSI) NGS result will reflex to MSI by PCR if tumor percentage is ≥40% and paired normal tissue is available.
Special Instructions
Ensure the FFPE tissue is stored and transported with a cold pack, avoiding direct contact with the specimen. NYS clients should provide date and time of collection.
Limitations
The test may have limitations in cases where the tumor percentage is below 40% or paired normal tissue is unavailable for reflex testing. The accuracy of the results can be affected by specimen quality and handling.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Paraffin block preferred. Use 10% buffered formalin fixative.
Storage Instructions
Use cold pack for transport, making sure cold pack is not in direct contact with specimen.